论文常用三线表模板.docx

1、论文常用三线表模板*欧阳光明*创编3.1 般资料2021.03.07欧阳光明（2021.03.07）2021.03.07表1护士一般资料情况（n=500）项目组别频数构成比（）性别女47895.6男224.4年龄段（岁）W2414929.825 2919639.23015531.0婚姻状况单身26052.0已婚2404&0护龄（年）W527054.061011523.0Nil11523.0学历中专193.8大专22244.4木科25150.2硕士81.6职称护士21442.8护师21042.0主管护师6913.8副主任护师71.4夜班次数0次5811.613次27955.84次及以上16332

2、.6个人年收入（元）4万15430.846万19639.2艮6万15030.0科室专科19939.8水欧阳光明*创编2021.03.07*欧阳光明*创编非专科 301 60.2表5不同年龄段护士专业生活质量得分的比较（乂士 S）维度年龄段（n=500）PW24 岁(n=149)2529 岁(n=196)F230 岁(n=155)同情满总：32.177.1131.068.0532.427.611.6100.201职业倦怠27.53 4.5127.04+4.3227.95 4.771.7870.169继发性创伤应激21.7157322.41+53123.29i5.8713.0240.049*专业生

3、活质虽总分81.4112.5580.50 12.7183.66 13.262.6990.068注：*Pv0.05; I表示与24岁组比较差异有统计学意义。表3不同组小鼠肝脏P-JNK平均灰度值结果比较（-S）分组例数P-JNK FPA组（正常组）8118.995.95B组（模型对照组）8101.05522C 组(DIVISO 组)8102.115.63b15.3860.00 rD组（低剂虽SP600125组）8107.965.36cE组（商剂址SP600125组）8113.965.50注： 0.05 ;与正常组比较,P 0.05;c与DMSO组比较，P 0.05 ; d与低剂量组比较，P0.0

4、5o表3干预组与对照组与减肥支持者沟通情况比较项目类别 -预组（n=65）对照组（n=63）rPn%n%锻炼减肥支持者A父母355&33555.6老师11.534.8同学9334.80.510父母/老师57.711.6父母/老师/同学1827.71523.8其他46.269.5沟通频率至少每天一次2233.81727.0至少每个星期一两次2233.81930.2至少每个丿J 一两次81231727.00.321至少每年一两次46.246.3至少一年一次913.869.5沟通满总度不满意710.8711.1中立2944.63454.01.3270.515满意2944.62234.9注：Fishe

5、r确切概率法，非参数检验。2021.03.07*欧阳光明*创编*欧阳光明*创编表5不同测量指标ROC曲线下面积比较结果30岁0.060.540.010.921.06 (0.37-3.05)彼劳）文化程度（参照组二中专） 大专0.790377.09o.or2.20(1.06-4.55)*木科及以上0.890397.4711年0.230.38000.751.25 (0.59-2.65)职称（参照组=护七） 护师-0.860.631.90070.44 (0.12-1.44)主管护师及以上0.040.930.010.921.04 (0.17-6.45)年收入（参照组=4万）46万0.380.39050

6、.701.46 (0.68-3.14)36万0.860.571.520.222.36 (0.77-7.22)水欧阳光明*创编*欧阳光明*创编 2021.03.07科室（参照组二非专科）-0.090.470.040.850.91 (0362.29)r=2 (中度年龄段（参照组=24岁）2529岁0.530.580.820.371.69 (0.54-5.33)同情330岁-0.650.600.660.420.52 (0.16-1.69)疲劳）文化程度（参照组=中专） 大专0.860.4116.45o.or2.36( 1.05-5.27)0木科及以上0.910.4317.440.01 2.48 (1

7、.07-5.77)0护龄（参照组=冬5年610 年0.790.493.050.082.20 (0.84-5.75)Mil年0.540.351350.251.71 (0.86-3.41)职称（参照组=护七）护师-0.330.590.310.580.72 (0.27-2.59)主管护师及以上-0.020.890.010.920.98 (0.17-5.72)年收入（参照组=4万）46万0.510.460.640.421.66 (0.68-4.10)N6万1.150.544.500.03，3.16(1.09-9.10)*科室（参照组二非专科）060.45030.721.18(0.49-2.81)：以Y

8、=0（无同情疲劳）作为参照组.拟合 2. 3时的多分类logistic回归方程。 : P0.05c表1两组乳腺癌患者体温结果比较（壬土S, C ）组别例数术前1天手术日术后1天术后3天术后7天观察组3036.60.236.30.436.1023630.336.40.4对照组3036.6023620435.2O.3A3590护36.303注：*与对照组比较,P0.05;与术前1天比较,P0.05o表2两组乳腺癌患者不同时间II压、心率结果比较GS）指标组别术前1天手术日术后1天术后3天术后7天SBP观察组117.6410.2814646121严127.3l12.27A114.827.64-120

9、.139.16(mm Hg)对照组149.247.22161.74i8.33*156.247.6f151376.34149.046.77DBP观察组78168.1876.898.6377.9792678.546.4379087.86(mm Ilg)对照组76.168.1886.539.3476.01 8.6674.3278273.65+8.02HR观察组75.084.74112.0610.27807677378.283.6778.41 7.24(次/min)对照组76.084.74117.95834852438280.4638379.14355注：水与对照组比较.PV0.05; 与术前1天比较

10、，PvO.05。表4两组乳腺癌患者不同时间CRP、IL6 TNF-a结果比较2021.03.07(-S)指标组别例数术前1天术后1天术后3天CRP观察组301.260.988.762.626.73195(mg/L)对照组300.98 0.4611.75 3.179.69 2.68IL-6观察组304.57 1.415.985623.15248(pg/mL)对照组304.83 1.496.86 3.765.07 3.07TNF-a观察组30& 112.178.57278.21 1.73*水欧阳光明*创编 *欧阳光明*创编 2021.03.07（pg/mL） 对照组 3 7.22 1.42 10.

11、943.24 9.31 2.43注：，与对照组比较，PvO.05; 与术前1天比较,P0.05o表1联合组和单用组患者治疗前后细胞因子比较（乂士S）组别例数TNF-a (ng/L)IL-6 (ng/L)IL-18 (ng/L)治疗前治疗后治疗前治疗后治疗前治疗后联合组5072.32 22.8731.01 12.45*350.10 38.74107.91 1839a61.1020.7433.91 15.39单用组5070.31 21.7548.5315.5P346.04 37.65162.32 20.40a63.04 21.6541.32 土 184(Pt0.4506.2290.53114.00

12、80.4582.184P0.6530.001*0.5960.05） o2.32红细胞参数 对照组RBC、Hb、HCT3个红细胞参数在手术后1、3天较术前一天显著降彳氐（Pv0.05）; MCV、MCH、MCHC这3个红细胞形态参数在术后几个时间点内较术前水平差异均无显著性（P0.05）,只有RDW-SD值于术后一天较术前一天明显增大（P0.05）（表 3）。表3两组乳腺癌患者不同时间血常规结果比较（云土S）指标组别例数术前1天术后1天术后3天WBC观察组308.251.209.161.1548.641.33(xlO9/L)对照组30&231613.811.27A11.424.64ARBC观察组

13、304.320244.580.194.600.20(xlOl2/L)对照组304.260.293190.263.600.3 广Hb观察组30120.075.77116.635.84117.165.37(g/L)对照组30118.085.79103.27土& 13厶1 10.438.76a观察组300.370.020.360.030.360.02HCT对照组300380.030.31 0.02O.32O.O3a*欧阳光明*创编 2021.03.07*欧阳光明*创编2021.03.07MCV观察组3079.647.7280.726.2080.565.46(fL)对照组3078.858.1183.3

14、367480.997.32MCH观察组3028.251.2030.361.1530.641.33(pg)对照组3027.271.1628.181.6727.731834MCHC观察组30324329.243345899341609.20(g/L)对照组30334.46929336.01 9.26334.70941RDW-SD观察组3037.6950640.135.34*38.255.27(fL)对照组303& 0857949.278.13a37.438.76PLT观察组30243.374902140.553743210.5145.02(xlO9/L)对照组30240.3845.03150.383102220.364203ANC观察组303.861.724.521.6044.391.67*(xlO9/L)对照组303.8518.33178.99132二2021.03.07注：与对照组比较，PvO.05; 与术前1天比较，P0.05o水欧阳光明*创编